{"protocolSection":{"identificationModule":{"nctId":"NCT00001823","nctIdAliases":["NCT00019799"],"orgStudyIdInfo":{"id":"990128"},"secondaryIdInfos":[{"id":"99-C-0128"}],"organization":{"fullName":"National Institutes of Health Clinical Center (CC)","class":"NIH"},"briefTitle":"Evaluation for NCI Surgery Branch Clinical Research Protocols","officialTitle":"Evaluation for NCI Surgery Branch Clinical Research Protocols"},"statusModule":{"statusVerifiedDate":"2024-08-05","overallStatus":"RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"1999-07-11","type":"ACTUAL"},"studyFirstSubmitDate":"1999-11-03","studyFirstSubmitQcDate":"1999-11-03","studyFirstPostDateStruct":{"date":"1999-11-04","type":"ESTIMATED"},"lastUpdateSubmitDate":"2024-08-17","lastUpdatePostDateStruct":{"date":"2024-08-20","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"National Cancer Institute (NCI)","class":"NIH"}},"oversightModule":{"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"Background:\n\nThe National Cancer Institute Surgery Branch (NCI-SB) has developed experimental therapies that involve taking white blood cells from patients' tumor or from their blood, growing them in the laboratory in large numbers, and then giving the cells back to the patient.\n\nObjective:\n\nThis study will allow patients to under screening and evaluation for participation in NC-SB Protocols.\n\nEligibility:\n\nPatients 18 years or older must meet the minimum eligibility criteria for an NCI-SB treatment protocol.\n\nDesign\n\nPatients will undergo testing and evaluations as required by the appropriate NCI-SB treatment protocol.","detailedDescription":"Background:\n\nPotential research candidates undergo thorough screening including laboratory tests, scans, x-rays, and review of pathology slides to determine initial eligibility for National Cancer Institute Surgery Branch (NCI-SB) research protocols.\n\nObjectives:\n\nPermit evaluation of patients referred to the NCI-SB in order to identify individuals who will be suitable candidates for NCI-SB clinical research protocols.\n\nTo assess frequency of HLA type, gene specific mutations or expression of neo antigens in malignant tumors across the population of cancer patients undergoing screening for NCI-SB protocols.\n\nCollect results of screening tests for use on subsequent research protocol as baseline (e.g., pretreatment) values.\n\nEligibility:\n\nAge \\>= 18 years.\n\nPatient suspected of having, or with biopsy proven, malignant disease.\n\nPatient is able to understand and willing to sign a written informed consent document.\n\nPatient is being evaluated for treatment on an NCI-SB protocols..\n\nDesign:\n\nPatients enrolled on this protocol will be evaluated by NCI-SB physicians to determine the individual's suitability for participation in a clinical research protocol. An accrual ceiling of 7,000 patients has been set to meet the screening needs of the NCI-SB."},"conditionsModule":{"conditions":["Synovial Cell Cancer","Melanoma","Colorectal Cancer","Lung Cancer","Bladder Cancer"],"keywords":["Cancer","Gene Therapy","Immunotherapy","Clinical Trial"]},"designModule":{"studyType":"OBSERVATIONAL","designInfo":{"observationalModel":"COHORT","timePerspective":"PROSPECTIVE"},"enrollmentInfo":{"count":7000,"type":"ESTIMATED"}},"armsInterventionsModule":{"armGroups":[{"label":"A/Surgery Branch Protocol Candidates","description":"Patients suspected of having, or with biopsy proven, malignant disease being evaluated for or treated on NCI Surgery Branch protocols"}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Number of individuals suitable for NCI Surgery Branch clinical research protocols","description":"Total number of patients who enroll on NCI Surgery Branch clinical research protocols","timeFrame":"25 Years"},{"measure":"Frequency of HLA type, gene specific mutations, or expression of neoantigens in malignant tumors","description":"Frequency of HLA type, gene specific mutations, or expression of neoantigens in tissue and blood samples","timeFrame":"25 years"},{"measure":"Results of screening tests","description":"Results of screening tests for use on subsequent research protocol as baseline (e.g., pretreatment) values","timeFrame":"25 years"}]},"eligibilityModule":{"eligibilityCriteria":"* INCLUSION CRITERIA:\n\nAge \\>= 18 years.\n\nPatient suspected of having, or with biopsy proven, malignant disease.\n\nPatient is able to understand and willing to sign a written informed consent document.\n\nPatient is being evaluated for treatment on an NCI-SB protocols.\n\nEXCLUSION CRITERIA:\n\nWomen of child-bearing potential who are pregnant or plan to become pregnant because of the potentially dangerous effects of some of the screening procedures (e.g., nuclear medicine or other imaging scans) on the fetus.","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"],"studyPopulation":"Patients suspected of having, or with biopsy proven, malignant disease.","samplingMethod":"NON_PROBABILITY_SAMPLE"},"contactsLocationsModule":{"centralContacts":[{"name":"NCI SB Immunotherapy Recruitment Center","role":"CONTACT","phone":"(866) 820-4505","email":"irc@nih.gov"}],"overallOfficials":[{"name":"Steven A Rosenberg, M.D.","affiliation":"National Cancer Institute (NCI)","role":"PRINCIPAL_INVESTIGATOR"}],"locations":[{"facility":"National Institutes of Health Clinical Center","status":"RECRUITING","city":"Bethesda","state":"Maryland","zip":"20892","country":"United States","contacts":[{"name":"For more information at the NIH Clinical Center contact National Cancer Institute Referral Office","role":"CONTACT","phone":"888-624-1937"}],"geoPoint":{"lat":38.98067,"lon":-77.10026}}]},"referencesModule":{"seeAlsoLinks":[{"label":"NIH Clinical Center Detailed Web Page","url":"https://clinicalstudies.info.nih.gov/cgi/detail.cgi?A_1999-C-0128.html"}]},"ipdSharingStatementModule":{"ipdSharing":"YES","description":".All IPD recorded in the medical record will be shared with intramural investigators upon request.","infoTypes":["STUDY_PROTOCOL","SAP","ICF"],"timeFrame":"Clinical data will be available during the study and indefinitely.","accessCriteria":"Clinical data will be made available via subscription to BTRIS and with the permission of the study PI."}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-08-28"},"conditionBrowseModule":{"meshes":[{"id":"D000015179","term":"Colorectal Neoplasms"},{"id":"D000001749","term":"Urinary Bladder Neoplasms"}],"ancestors":[{"id":"D000007414","term":"Intestinal Neoplasms"},{"id":"D000005770","term":"Gastrointestinal Neoplasms"},{"id":"D000004067","term":"Digestive System Neoplasms"},{"id":"D000009371","term":"Neoplasms by Site"},{"id":"D000009369","term":"Neoplasms"},{"id":"D000004066","term":"Digestive System Diseases"},{"id":"D000005767","term":"Gastrointestinal Diseases"},{"id":"D000003108","term":"Colonic Diseases"},{"id":"D000007410","term":"Intestinal Diseases"},{"id":"D000012002","term":"Rectal Diseases"},{"id":"D000014571","term":"Urologic Neoplasms"},{"id":"D000014565","term":"Urogenital Neoplasms"},{"id":"D000052776","term":"Female Urogenital Diseases"},{"id":"D000005261","term":"Female Urogenital Diseases and Pregnancy Complications"},{"id":"D000091642","term":"Urogenital Diseases"},{"id":"D000001745","term":"Urinary Bladder Diseases"},{"id":"D000014570","term":"Urologic Diseases"},{"id":"D000052801","term":"Male Urogenital Diseases"}],"browseLeaves":[{"id":"M11172","name":"Lung Neoplasms","relevance":"LOW"},{"id":"M5030","name":"Urinary Bladder Neoplasms","asFound":"Bladder Cancer","relevance":"HIGH"},{"id":"M11528","name":"Melanoma","relevance":"LOW"},{"id":"M17890","name":"Colorectal Neoplasms","asFound":"Colorectal Cancer","relevance":"HIGH"},{"id":"M10448","name":"Intestinal Neoplasms","relevance":"LOW"},{"id":"M8886","name":"Gastrointestinal Neoplasms","relevance":"LOW"},{"id":"M7256","name":"Digestive System Neoplasms","relevance":"LOW"},{"id":"M8883","name":"Gastrointestinal Diseases","relevance":"LOW"},{"id":"M7255","name":"Digestive System Diseases","relevance":"LOW"},{"id":"M6336","name":"Colonic Diseases","relevance":"LOW"},{"id":"M10444","name":"Intestinal Diseases","relevance":"LOW"},{"id":"M14844","name":"Rectal Diseases","relevance":"LOW"},{"id":"M17320","name":"Urologic Neoplasms","relevance":"LOW"},{"id":"M17315","name":"Urogenital Neoplasms","relevance":"LOW"},{"id":"M2875","name":"Urogenital Diseases","relevance":"LOW"},{"id":"M27093","name":"Female Urogenital Diseases","relevance":"LOW"},{"id":"M14127","name":"Pregnancy Complications","relevance":"LOW"},{"id":"M8399","name":"Female Urogenital Diseases and Pregnancy Complications","relevance":"LOW"},{"id":"M5026","name":"Urinary Bladder Diseases","relevance":"LOW"},{"id":"M17319","name":"Urologic Diseases","relevance":"LOW"},{"id":"M27095","name":"Male Urogenital Diseases","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC04","name":"Neoplasms"},{"abbrev":"BC08","name":"Respiratory Tract (Lung and Bronchial) Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BXS","name":"Urinary Tract, Sexual Organs, and Pregnancy Conditions"},{"abbrev":"BC17","name":"Skin and Connective Tissue Diseases"},{"abbrev":"BC06","name":"Digestive System Diseases"}]},"interventionBrowseModule":{"browseLeaves":[{"id":"M2853","name":"Immunomodulating Agents","relevance":"LOW"}],"browseBranches":[{"abbrev":"All","name":"All Drugs and Chemicals"}]}},"hasResults":false}